Latest return on equity
Celldex Therapeutics Return on equity
Direct answer
Celldex Therapeutics's return on equity is -43.88%.
The verified market snapshot reports -43.88%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 17, 2026.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -43.88%
Explore related company data
View Celldex Therapeutics's market capitalizationView Celldex Therapeutics's price-to-book ratioView Celldex Therapeutics's dividend yieldView Celldex Therapeutics's 52-week price rangeView Celldex Therapeutics's revenue growthView Celldex Therapeutics's profit marginView Celldex Therapeutics's debt-to-equity ratioView all Celldex Therapeutics key metricsReturn to Celldex Therapeutics profile